Skip to main content
Top
Published in: Breast Cancer Research 1/2021

01-12-2021 | Breast Cancer | Correction

Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

Authors: Jia Yu, Bo Qin, Ann M. Moyer, Jason P. Sinnwell, Kevin J. Thompson, John A. Copland III, Laura A. Marlow, James L. Miller, Ping Yin, Bowen Gao, Katherine Minter-Dykhouse, Xiaojia Tang, Sarah A. McLaughlin, Alvaro Moreno-Aspitia, Anthony Schweitzer, Yan Lu, Jason Hubbard, Donald W. Northfelt, Richard J. Gray, Katie Hunt, Amy L. Conners, Vera J. Suman, Krishna R. Kalari, James N. Ingle, Zhenkun Lou, Daniel W. Visscher, Richard Weinshilboum, Judy C. Boughey, Matthew P. Goetz, Liewei Wang

Published in: Breast Cancer Research | Issue 1/2021

Login to get access

Excerpt

Correction to: Breast Cancer Research 19, 130 (2017)
Metadata
Title
Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study
Authors
Jia Yu
Bo Qin
Ann M. Moyer
Jason P. Sinnwell
Kevin J. Thompson
John A. Copland III
Laura A. Marlow
James L. Miller
Ping Yin
Bowen Gao
Katherine Minter-Dykhouse
Xiaojia Tang
Sarah A. McLaughlin
Alvaro Moreno-Aspitia
Anthony Schweitzer
Yan Lu
Jason Hubbard
Donald W. Northfelt
Richard J. Gray
Katie Hunt
Amy L. Conners
Vera J. Suman
Krishna R. Kalari
James N. Ingle
Zhenkun Lou
Daniel W. Visscher
Richard Weinshilboum
Judy C. Boughey
Matthew P. Goetz
Liewei Wang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2021
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-021-01420-z

Other articles of this Issue 1/2021

Breast Cancer Research 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine